COVID: Biological E Gets DCGI Nod To Conduct Phase 2/3 Trials On Children

The Drug Controller General of India (DCGI) has granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials for its anti-Covid shots called Corbevax on children. The trial will be on children between 5 and 18 years of age with certain conditions. ....

 

Full Story